#INCB

[jamesgierach]

THE GIERACH MESSAGE TO CHICAGO’S WEST AND SOUTH SIDES

by James E. Gierach

I earnestly want the violence on the West and South Sides of Chicago STOPPED. As a former Cook County ASA, violence prosecution was my job. For more than 30 years I have advanced the idea that drug prohibition (the War on Drugs) causes endless violence, feeds the gangs, buys the guns, tempts the young and fills the prisons. I advanced that idea as a political candidate, writer, and international speaker. The choice is drug prohibition or safe communities, one or the other but not both.

Drugs can do, and often do, terrible things to individuals and their families. As a consequence, our intuitive, reflexive nature leads us to believe that drugs are “bad,” and therefore, should be outlawed (prohibited). We believe the politicians’ spiel, because we want to save our kids, save one another, and save society. But, unfortunately, outlawing drugs supports gangbangers, drug dealers and tempts an endless supply of new recruits (kids) to see drugs as a way to support themselves.

Like Al Capone supported the prohibition of liquor, drug dealers and drug cartels support prohibition of many other drug choices.

WE, THE PEOPLE, must stop supporting gangs and drug dealers; WE, THE PEOPLE, must stop supporting drug prohibition. We must defund the gangs, not the police.

It’s easy for politicians (aldermen, state reps, senators, congressmen and U.S. senators) to condemn violence and drugs, but then support drug prohibition that feeds the gangs, buys the guns, invents and imports the drugs, drives immigrants to our southern border, funds terrorists, and causes unending violence, cultural decline and value erosion.

Even now with record amounts of public and private funding for stop-the-violence initiatives (violence interrupters, job opportunities for kids, community investment, …), the violence continues as if the mayor, the private donors and the do-gooders have done nothing.

The reason these initiatives have failed, and will fail, is because all stop-the-violence initiatives must be taken with the poison pill—drug prohibition.

So, how do we END DRUG PROHIBITION TO STOP THE VIOLENCE?

Oh, no! Not that! Not DRUG LEGALIZATION!

Violence like the St. Valentine’s Day Massacre ended when alcohol was legalized. Why shouldn’t we expect the same when other drugs are legalized?

The Silver Bullet Solution is difficult to swallow but swallow it we must, if we are serious about STOPPING CHICAGO VIOLENCE.

I’m afraid if I say these things, again, as I did as a candidate for state’s attorney and then Illinois governor (1992 and 1994), the West and South Sides of Chicago, again, will not hear my message. But the message must be heard and acted upon, if violence is to dramatically decline.

Therefore, I message ALL readers. Will you help me carry my unwelcome “Silver Bullet Solution” to your community?

I have written “The Case for Ending the War on Drugs.” Will you help me promote the ideas in my book on the West Side and South Sides of Chicago? I stand ready, willing and able to help.

But public policy change requires changed public opinion regarding how we deal with drugs. Without public opinion supporting drug legalization, politicians, who have the power to continue or end the War on Drugs, will not act to end it. Please help.

Here is information about the book, I’ve written. Please spread the word.

https://histriabooks.com/product/the-silver-bullet-is-it-time-to-end-the-world-war-on-drugs/

Thank you for listening.

Palos Park, Illinois

1-708-951-1601

drugnews1@yahoo.com

http: jamesgierach@tumblr.com

June 6, 2023

[tonieletronica-blog]

Download INCB Eletrônica 23 Revista em PDF https://te1.com.br/?p=45772 Por Toni Rodrigues Toni Eletrônica Circuitos...

[k2blogg]

Crafting Policy: Strategies to Control Synthetic Drug Epidemics

Crafting Policy: Strategies to Control Synthetic Drug Epidemics

The emergence of synthetic drugs, including synthetic cannabinoids like K2 Spice, presents significant challenges for policymakers seeking to protect public health and safety. Crafting effective policy responses to control synthetic drug epidemics requires a multifaceted approach that addresses the complex factors driving their production, distribution, and use. In this article, we explore strategies for policymakers to control synthetic drug epidemics and mitigate their impact on communities.

Comprehensive Regulation

One of the key strategies for controlling synthetic drug epidemics is a comprehensive regulation that targets the production, distribution, and sale of synthetic drugs. This may include banning specific compounds or classes of compounds, regulating precursor chemicals used in their manufacture, and imposing strict penalties for those involved in their production and distribution. Comprehensive regulation helps limit the availability of synthetic drugs and reduces the risk of harm to individuals and communities.

International Cooperation

Given the global nature of the synthetic drug trade, international cooperation is essential for controlling synthetic drug epidemics effectively. Policymakers must work together across borders to share information, coordinate enforcement efforts, and disrupt the trafficking networks responsible for the production and distribution of synthetic drugs. International organizations, such as the United Nations Office on Drugs and Crime (UNODC) and the International Narcotics Control Board (INCB), play a crucial role in facilitating cooperation and supporting countries in their efforts to control synthetic drug epidemics.

Public Education and Prevention

Public education and prevention efforts are essential components of any strategy to control synthetic drug epidemics. Policymakers must invest in public awareness campaigns that raise awareness about the risks of synthetic drugs and promote positive behaviors, such as avoiding substance use and seeking help for addiction. Additionally, prevention programs targeted at vulnerable populations, such as adolescents and young adults, can help reduce the demand for synthetic drugs and prevent the onset of substance use disorders.

Treatment and Rehabilitation

Access to treatment and rehabilitation services is critical for individuals struggling with synthetic drug addiction. Policymakers must ensure that adequate resources are available to support individuals in need of treatment, including evidence-based interventions such as medication-assisted treatment, counseling, and support groups. Additionally, policymakers should work to remove barriers to treatment, such as lack of insurance coverage or stigma surrounding substance use disorders, to ensure that all individuals have access to the care they need.

Monitoring and Surveillance

Monitoring and surveillance of the synthetic drug market are essential for policymakers to stay informed about emerging trends and developments. Policymakers should invest in systems for monitoring the availability, use, and effects of synthetic drugs, including data collection, analysis, and reporting mechanisms. This information can help policymakers identify emerging threats, assess the effectiveness of existing policies, and tailor interventions to address specific needs and challenges.

Conclusion

Controlling synthetic drug epidemics requires a coordinated and comprehensive approach that addresses the complex factors driving their production, distribution, and use. By implementing strategies such as comprehensive regulation, international cooperation, public education and prevention, treatment and rehabilitation, and monitoring and surveillance, policymakers can work to mitigate the impact of synthetic drug epidemics and protect public health and safety. Through collaborative efforts and evidence-based interventions, we can control synthetic drug epidemics and support individuals and communities affected by these dangerous substances.

[pacosemnoticias]

Portugal regista o segundo maior consumo do mundo de fármaco para insónias

Portugal registou em 2022 o segundo maior consumo do mundo do fármaco de combate à insónia zolpidem, e um dos maiores do anestésico e sedativo cetamina, segundo o relatório do Conselho Internacional para o Controlo de Narcóticos (INCB).

O Uruguai relatou ao INCB o nível mais alto de consumo de zolpidem em todo o mundo em 2022, seguido por Portugal, mas no geral, entre os 64 países e territórios que forneceram dados, o consumo médio de zolpidem na Europa "foi significativamente maior" do que em outras regiões.

Assim como o diazepam e o fenobarbital, o zolpidem é uma das substâncias psicotrópicas mais comercializadas sob controlo internacional, destaca o organismo, adiantando que a sua produção aumentou de 38,2 toneladas em 2021 para 39,1 toneladas em 2022.

Pela primeira vez, este relatório contém dados do consumo de cetamina, que em 2022 aumentou em toda a Europa, sendo as maiores ocorrências observadas em cidades de Portugal, Espanha, Itália e Dinamarca.

O Observatório Europeu da Droga e da Toxicodependência (OEDT) e o Gabinete das Nações Unidas contra a Droga e a Crime (UNODC) assinalaram um aumento no uso não médico de cetamina em toda a Europa em 2022, o que o INCB diz suscitar preocupações sobre potenciais implicações graves para a saúde.

Bélgica, França, Itália e Espanha registaram um aumento no número de pessoas que procuraram tratamento para o uso da substância, sublinhando o INCB a necessidade de uma monitorização rigorosa do uso e impacto na saúde pública.

O relatório dá conta de que, de dezembro de 2022 a janeiro de 2023, vários países europeus, entre os quais Portugal, participaram numa operação do INCB para combater a produção e distribuição ilícitas de diversas substâncias, incluindo a cetamina, que estava a ser traficada através de serviços postais e de correio expresso.

O relatório anual do OEDT sobre águas residuais incluiu dados de 104 cidades que revelaram que o uso de cocaína permanece alto em cidades localizadas no oeste e no sul Europa, em particular Portugal, Espanha, Bélgica e Países Baixos.

Também as maiores ocorrências de MDMA (popularmente conhecido como ecstasy) foram encontradas em Portugal, Espanha, Bélgica e Países Baixos, segundo o documento.

O INCB assinala o "rápido surgimento" no mercado de uma gama mais ampla de substâncias e um padrão cada vez mais complexo de consumo de drogas, avisando que o conhecimento limitado sobre os riscos para a saúde de novas drogas sintéticas coloca "desafios significativos" ao fornecimento de tratamento e serviços destinados a reduzir os efeitos negativos na saúde e consequências sociais do uso de tais drogas.

"Deve ser prestado maior apoio às autoridades responsáveis pela aplicação da lei e autoridades de saúde na monitorização da situação e na educação dos consumidores sobre os riscos para a saúde do policonsumo de drogas", alerta.

O organismo critica ainda, no documento, os vários países europeus que continuaram a estabelecer mercados regulamentados de canábis para fins não médicos: "Estes programas não parecem ser consistentes com as convenções de controlo de drogas", avisa.

[mensusaonlinestore1]

IMPORTANT INFORMATIONS AND WARRNINGS REGARDING CANNABIS EVERYONE MUST KNOW

There are lot of things is going in the world regarding cannabis.

Some says it have lot of health benefits and some say it have no health benefits.

Many countries (In fact most of the countries) already banned cannabis uses no matter it is for medical purpose or consumptions purposes.

Recently the International Narcotics Control Board (INCB) is warning in its Annual Report 2022 that legalizing the non-medical use of cannabis, which contravenes the 1961 Single Convention on Narcotic Drugs, seems to result in higher consumption and a lower perception of risk, especially among young people.

Before you use cannabis for medical purposes, make sure if you are consuming it then make sure you are away from certain kind of people.

WHICH KIND OF PEOPLE COULD BE IN RISKY IF CANNABIS CONSUMED IN WRONG WAY?

The following kind of people would be in risky if cannabis consumed in wrong way and they are –

Children

Adolescents

Young adults

Women , who are pregnant

Women , who are breastfeeding

Persons with a personal or family history of psychotic disorder such as schizophrenia

Most of the use of cannabis related products are experimental. Use of cannabis may or may give you relief from certain symptoms however also comes with lot of side effects like - dizziness, fatigue, dry mouth, light-headedness, drowsiness, and nausea etc and more. Side effects could be from mild to moderate and may present until the effect of cannabis remains in your body. They are unknown each time a patient starts taking any new medication and these unknown are particularly prominent for medical cannabis.

Cannabis also could be very problems for women who are pregnant as well. If you are a women, prescribed by doctor to use cannabis be cautious regarding cannabis as well if you are planning to bring a baby. Cannabis could also be very serious for those people who are breastfeeding. Don’t smoke cannabis in front of them.

People who have serious heart problems or liver diseases should also refrain from consuming vaporizer for weed directly or indirectly.

While you are consuming cannabis or consuming cannabis, one must not drive cars or do any work which may involve risks if not done correctly.

To avoid having unpleasant side effects, it is best to start at a low dose and then increase the dose slowly over time until symptoms are relieved or side effects develop. Pharmacists at the Cannabis Patient Centers will follow this methodology. Talk to the pharmacist at a Cannabis Patient Center about recommendations for how to increase dosage and what to do if side effects appear. You might want to purchase less than a 30-day supply of medical cannabis during your first few visits to a Cannabis Patient Center until you learn how you respond to a particular medical cannabis product.

If you are going to move to a new country, where cannabis is not legal make sure you are not using it.

The cannabis industry is still new and looking for new direction. Scientists are still doing research of how we can use cannabis for better ways.

Canada is the only G7 countries which has framed law regarding cannabis and legalize cannabis use for medical purposes.

In USA, though there is no federal level law, yet it states framed many law in many states with their own capacity. 

PURI5 is the company which sells variety type and kind of vaporizers, Dabs and herbs vape pen from various companies etc and so on.

We not only sell vaporizers but also sell its parts and accessories as well.

If you are looking to do wholesale business with us, we also provide that as well.

[mirandamckenni1]

ONZ sugeruje, że rząd USA musi zmusić stany do wycofania się z legalizacji marihuany

Międzynarodowa Rada Kontroli Narkotyków (INCB), organ Organizacji Narodów Zjednoczonych (ONZ) odpowiedzialny za kontrolę narkotyków, sugeruje, że Stany Zjednoczone nie przestrzegają międzynarodowej umowy narkotykowej z 1961 roku, ponieważ rząd federalny pozwala poszczególnym stanom w kraju na legalizację marihuany dla dorosłych. from [H]yperreal - newsy https://ift.tt/DeOQ4ph

[apsny-news]

"Madde kullanım yaşı düşüyor; Diyarbakır ve İstanbul önde gidiyor"

Birleşmiş Milletler Uyuşturucu Kontrol Kurulu (INCB) 2022 Raporu, 9 Mart’ta açıklandı. Rapora göre; Türkiye’de ve dünyada tütün, alkol ve uyuşturucu kullanımları hızla artıyor, uyuşturucu maddelere başlama yaşı ise; gittikçe düşüyor. Türkiye’de metamfetamin yakalamalarında ciddi artış görülüyor. Raporda, 2019’da 1 ton, 2020’de 4,1 ton, 2021’de 5,5 ton metanfetamin ele geçirildiği ifade ediliyor.…

[cavenewstimes]

UN Issues ‘Warning’ to U.S. Over Adult-Use State Laws, Suggesting Repeal

The United Nations’ (UN) narcotics watchdog issued a press release on March 9, saying that U.S. adult-use cannabis laws are out of sync with the 1961 Single Convention on Narcotic Drugs, (with roots in Reefer Madness) and that the “trivialization” of youth harms from cannabis is a major cause for concern. The UN’s International Narcotics Control Board (INCB) said that it is “warning” in its…

[nycannabistimes]

#Repost @cannabisworldjournals ・・・ While the regularization of cannabis for adult use has already gone through several debates in Congress and there is the possibility of constitutional reform in this regard, the vice president of the International Narcotics Control Board (INCB) ensures that the legalization of this substance has not managed to reduce drug use (Nuevo Siglo, 2023). The second vice president of the INCB, César Arce Ríos, assured in an interview with UN News that the legalization of cannabis for recreational use has not been able to reduce drug use and the illicit narcotics markets persist, according to the annual report made by this board. (New Century, 2023) We view with concern the trivialization regarding the non-medical use of cannabis, and the trend towards its legalization, mainly in Latin America and part of Europe, highlighted César Arce Ríos. (New Century, 2023) The vice president of the INCB has insisted that the legalization of cannabis has not fulfilled what was proposed: "The objective was to reduce or eliminate organized crime that is dedicated to the sale of cannabis and it has not been achieved, it has even grown in some countries. It was also intended to have a regulated and controlled market so that cannabis did not reach minors and it has not been fulfilled either ". (New Century, 2023) Learn more relevant information on our page Link in their bio (at Times Square, New York City) https://www.instagram.com/p/CpvxbRfscLH/?igshid=NGJjMDIxMWI=

[jamesgierach]

AN OPEN LETTER TO THE COMMISSION ON NARCOTIC DRUGS 2024

RE: AMEND UNITED NATIONS “DRUG-CONTROL” CONVENTIONS

UNODC: Please forward this email to the CND Chair and all Vice Chairs.

Dear Chairman Philbert Isaac Kobina Abaka Johnson:

I write to bring your attention to the failure of UN “drug-control” treaties. Every year in advance of the annual March CND session in Vienna, a report on drug use and another on drug trafficking are produced. Those reports evidence, without fail, that the recreational drug use prohibition, intolerance and punishment paradigm is a drugogenic, criminogenic and corruptogenic failure.

Special sessions of the UN General Assembly regarding “the drug problem,” most recently UNGASS2016, likewise collect evidence of that failure, despite giving rise to hope that the future will be better. But it never is better. Reports regarding new drugs, new precursors, more overdose deaths, more health problems, more death penalty punishment, more violent crime and corruption follow UN drug prohibition like a permanent tattoo or darkened shadow, impeaching the very relevance and usefulness of the United Nations.

I believe in the United Nations idea, its potential and the critical need for it, if we are to collectively enjoy a better future, or I would not be writing. The IDPC Shadow Report prepared preliminary to UNGASS2016 documented, using UN-collected data, the systematic, unrelenting failure of the drug prohibition paradigm. Reports and books documenting the UN drug policy failure since 1961 fill libraries.

Secondly, I write to introduce you to my book released late November, The Silver Bullet Solution: Is it time to end the War on Drugs? (Gaudium, 2023), https://www.amazon.com/Silver-Bullet-Solution-time-Drugs/dp/1592113389/ref=tmm_hrd_swatch_0?_encoding=UTF8&qid=&sr=. I encourage you and every 53 voting CND Member State representatives to read it. All UN ambassadors, representatives, attendees and national and world leaders should also read it.

Without any nation having filed a proposed amendment of UN drug conventions with the Secretary-General, sadly, there is no hope for any productive outcome of this years’s CND session. Talk of human rights, harm reduction and drug policy reform is not action for reform. Statements are just statements, much like this letter. I know UNODC, INCB and CND realize that fact as these UN agencies zealously guard and protect UN drug gospel from amendment—the Treaty Trilogy of UN Drug Prohibition. Like it or not, that gospel is the foundation of the “World War on Drugs.” But UN drug-control treaties desperately need amendment, as I called for in a CND side event in 2015. I drafted several such amendments on behalf of Law Enforcement Against Prohibition, now known as Law Enforcement Action Partnership (LEAP), to demonstrate how easy the process can be. (Please Note: I no longer am affiliated with LEAP.)

In any event, without any hope of meaningful change at CND this year, I will not attend or speak.

But optimistically, and respectfully, I hope my letter and my book will encourage you and other CND chairs and members will charge UNODC, Civil Society, experts, and others, with the task of conceptualizing and drafting proposed amendments of UN drug-control conventions for CND consideration and adoption next year.

Kind regards,

James E. Gierach

Palos Park, Illinois 60464 USA

drugnews1@yahoo.com

#CND #INCB #UNODC #IDPC #ACLU #drug-prohibition #crime #overdose #AIDS #corruption #drugs #violence #UN

[tonieletronica-blog]

Download INCB Eletrônica 23 Revista em PDF https://te1.com.br/?p=45772 Por Toni Rodrigues Toni Eletrônica Circuitos...

[k2blogg]

Legal Battles: The Fight Against Synthetic Cannabinoids

Legal Battles: The Fight Against Synthetic Cannabinoids

Synthetic cannabinoids, often marketed as "legal highs" or "herbal incense," have sparked a legal battle in many jurisdictions worldwide. Despite efforts to regulate and ban these substances, manufacturers continue to create new formulations to evade legal restrictions, presenting significant challenges for law enforcement and policymakers. In this article, we delve into the legal battles surrounding synthetic cannabinoids, exploring the complexities of regulation and the ongoing fight against these dangerous substances.

Evolving Legislation

The regulation of synthetic cannabinoids is a constantly evolving process, with lawmakers attempting to keep pace with the rapid proliferation of new compounds. Initially marketed as "legal highs" and sold openly in stores and online, synthetic cannabinoids have faced increasing scrutiny from regulators as reports of adverse effects and public health concerns have emerged. In response, many countries have implemented bans on specific synthetic cannabinoids or classes of compounds, only to see manufacturers modify their formulas to circumvent these restrictions.

Cat-and-Mouse Game

The battle against synthetic cannabinoids often resembles a game of cat-and-mouse, with regulators attempting to stay one step ahead of manufacturers who continually tweak their formulas to skirt legal restrictions. As soon as one synthetic cannabinoid is banned, manufacturers introduce new compounds with slightly different chemical structures, exploiting legal loopholes and making it difficult for law enforcement to keep pace. This cat-and-mouse game poses significant challenges for regulators and highlights the need for innovative approaches to address the issue effectively.

International Cooperation

Given the global nature of the synthetic cannabinoid trade, international cooperation is essential for combating the problem effectively. Organizations such as the United Nations Office on Drugs and Crime (UNODC) and the International Narcotics Control Board (INCB) play a crucial role in facilitating cooperation among countries and coordinating efforts to address the trafficking and distribution of synthetic cannabinoids. However, challenges such as differences in legal frameworks, enforcement capacity, and resources can complicate international efforts to combat the problem.

Public Health Concerns

At the heart of the legal battle against synthetic cannabinoids are public health concerns about the risks posed by these substances. Synthetic cannabinoids are associated with a range of adverse effects, including psychosis, seizures, cardiovascular problems, and even death. Additionally, the unpredictable nature of synthetic cannabinoids makes them particularly hazardous, as users may be unaware of the potency or composition of the product they are consuming. As such, regulating synthetic cannabinoids is not just a legal issue but also a public health imperative.

Harm Reduction Strategies

In addition to regulatory measures, harm reduction strategies play a crucial role in addressing the risks associated with synthetic cannabinoids. These strategies may include public education campaigns, outreach to vulnerable populations, access to treatment and support services, and the provision of naloxone and other overdose reversal medications. By focusing on reducing the harms associated with synthetic cannabinoid use, harm reduction approaches complement regulatory efforts and help protect public health.

Conclusion

The legal battles surrounding synthetic cannabinoids highlight the complexities of regulating rapidly evolving substances that pose significant risks to public health and safety. While regulatory measures play an essential role in addressing the problem, they must be accompanied by international cooperation, public health interventions, and harm reduction strategies to be effective. By working together across sectors and borders, policymakers, law enforcement agencies, and public health professionals can continue the fight against synthetic cannabinoids and protect communities from the dangers posed by these substances.

[parolim-prlm]

UN drugs control board — Global Issues

Issuing the warning at the launch of its annual report, the International Narcotics Control Board (INCB) cited data indicating that the trend caused “negative health effects and psychotic disorders” among some recreational cannabis users, while also contravening the UN 1961 Single Convention on Narcotic Drugs. “In all jurisdictions where cannabis has been legalized, data show that…